Patents by Inventor Ross A. Stewart

Ross A. Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230391885
    Abstract: Antibodies and compositions against Claudin 18.2 and uses thereof are provided herein.
    Type: Application
    Filed: June 1, 2023
    Publication date: December 7, 2023
    Inventors: Ross Stewart Chambers, Joseph Benjamin Rucker, Brad Alan Screnci, Trevor Andrew Barnes, Timothy Robin Phillips, Benjamin J. Doranz
  • Publication number: 20230235062
    Abstract: Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7-H1 are disclosed. Additionally, hybridomas or other cell lines expressing such antibodies are disclosed.
    Type: Application
    Filed: November 1, 2022
    Publication date: July 27, 2023
    Inventors: CHRISTOPHE QUEVA, MICHELLE MORROW, SCOTT HAMMOND, MARAT ALIMZHANOV, JOHN BABCOOK, IAN FOLTZ, JASPAL SINGH KANG, LAURA SEKIROV, MELANIE BOYLE, MATTHIEU CHODORGE, ROSS A. STEWART, KATHLEEN ANN MULGREW
  • Patent number: 11648971
    Abstract: A foldable golf trolley comprising a chassis; at least one electrically powered rear drive wheel; a wheel support arm mounted to the front of the chassis supporting a front wheel; a stabilizer arm mounted to the rear of the chassis supporting a stabilizer wheel; a main support mounted to the chassis and a handle mounted to the main support; wherein the main support, the wheel support arm and the stabilizer arm are rotatably mounted to the chassis and movable between an operative configuration and a folded configuration; and gears connecting the stabilizer arm and main support, wherein rotation of the main support between the operative configuration and the folded configuration cause rotation of the stabilizer arm between the operative configuration and the folded configuration.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: May 16, 2023
    Assignee: STEWART GOLF LIMITED
    Inventors: Mark Stewart, Jon Stewart-Miller, David Funnell, Duncan Ross Stewart
  • Patent number: 11518809
    Abstract: Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7-H1 are disclosed. Additionally, hybridomas or other cell lines expressing such antibodies are disclosed.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: December 6, 2022
    Assignee: MEDIMMUNE LIMITED
    Inventors: Christophe Queva, Michelle Morrow, Scott Hammond, Marat Alimzhanov, John Babcock, Ian Foltz, Jaspal Singh Kang, Laura Sekirov, Melanie Boyle, Matthieu Chodorge, Ross A. Stewart, Kathleen Ann Mulgrew
  • Publication number: 20220372121
    Abstract: Peptides and uses thereof, such as a common light chain in an antibody, are provided.
    Type: Application
    Filed: February 3, 2022
    Publication date: November 24, 2022
    Inventors: Thomas Charpentier, Ross Stewart Chambers, Lewis J. Stafford, Trevor Barnes, Jonathan T. Sullivan
  • Publication number: 20220073622
    Abstract: Disclosed are methods for treating late stage (e.g., clinical stage III or IV), unresectable non-small-cell lung cancer (NSCLC) with an antibody that inhibits PD1/PD-L1 activity in a patient identified as having not progressed following definitive chemoradiation therapy.
    Type: Application
    Filed: November 18, 2021
    Publication date: March 10, 2022
    Inventors: Giovanni Melillo, Marc Ballas, Simon Dovedi, Ross Stewart
  • Publication number: 20210261181
    Abstract: A foldable golf trolley comprising a chassis; at least one electrically powered rear drive wheel; a wheel support arm mounted to the front of the chassis supporting a front wheel; a stabilizer arm mounted to the rear of the chassis supporting a stabilizer wheel; a main support mounted to the chassis and a handle mounted to the main support; wherein the main support, the wheel support arm and the stabilizer arm are rotatably mounted to the chassis and movable between an operative configuration and a folded configuration; and gears connecting the stabilizer arm and main support, wherein rotation of the main support between the operative configuration and the folded configuration cause rotation of the stabilizer arm between the operative configuration and the folded configuration.
    Type: Application
    Filed: February 23, 2021
    Publication date: August 26, 2021
    Inventors: Mark Stewart, Jon Stewart-Miller, David Funnell, Duncan Ross Stewart
  • Publication number: 20210017282
    Abstract: Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7-H1 are disclosed. Additionally, hybridomas or other cell lines expressing such antibodies are disclosed.
    Type: Application
    Filed: July 23, 2019
    Publication date: January 21, 2021
    Inventors: CHRISTOPHE QUEVA, MICHELLE MORROW, SCOTT HAMMOND, MARAT ALIMZHANOV, JOHN BABCOCK, IAN FOLTZ, JASPAL SINGH KANG, LAURA SEKIROV, MELANIE BOYLE, MATTHIEU CHODORGE, ROSS A. STEWART, KATHLEEN ANN MULGREW
  • Publication number: 20190276543
    Abstract: Disclosed are methods for treating late stage (e.g., clinical stage III or IV), unresectable non-small-cell lung cancer (NSCLC) with an antibody that inhibits PD1/PD-L1 activity in a patient identified as having not progressed following definitive chemoradiation therapy.
    Type: Application
    Filed: March 8, 2018
    Publication date: September 12, 2019
    Inventors: Giovanni Melillo, Marc Ballas, Simon Dovedi, Ross Stewart
  • Patent number: 10400039
    Abstract: Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7-H1 are disclosed. Additionally, hybridomas or other cell lines expressing such antibodies are disclosed.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: September 3, 2019
    Assignee: MEDIMMUNE LIMITED
    Inventors: Christophe Queva, Michelle Morrow, Scott Hammond, Marat Alimzhanov, John Babcock, Ian Nevin Foltz, Jaspal Singh Kang, Laura Sekirov, Melanie Boyle, Matthieu Chodorge, Ross A. Stewart, Kathleen Ann Mulgrew
  • Publication number: 20190192655
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Application
    Filed: September 5, 2018
    Publication date: June 27, 2019
    Inventors: ROSS A. STEWART, MICHELLE MORROW, ROBERT W. WILKINSON, EDMUND POON, SIMON DOVEDI, TIM ILLIDGE
  • Patent number: 10092645
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: October 9, 2018
    Assignee: MedImmune Limited
    Inventors: Ross Stewart, Michelle Morrow, Robert Wilkinson, Edmund Poon, Simon Dovedi, Tim Illidge
  • Patent number: 10077305
    Abstract: The present invention provides antibodies and antigen-binding fragments that specifically bind PD-1 (Programmed Death 1), thereby modulating immune responses in general, and those mediated by TcR and CD28, in particular. The disclosed compositions and methods may be used for example, in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer and other immune system disorders.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: September 18, 2018
    Assignee: MedImmune Limited
    Inventors: Andrew G. Buchanan, Ross Stewart, Mathieu Chodorge
  • Publication number: 20160347848
    Abstract: Provided herein are methods of treating a solid tumor comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof, tremelimumab or an antigen-binding fragment thereof, and MEDI6383.
    Type: Application
    Filed: May 9, 2016
    Publication date: December 1, 2016
    Applicant: MedImmune Limited
    Inventors: Scott A. HAMMOND, Kathleen Ann MULGREW, Michael OBERST, Edward BRADLEY, Ross A. STEWART
  • Publication number: 20160240096
    Abstract: A motion device, such as a flight simulator, including a frame including a plurality of roller assemblies mounted thereto and an at least partially rounded body supported on the roller assemblies. The roller assemblies are operable to contact an external surface of the body and to allow movement of the body in a pitch direction, a yaw direction and a roll direction relative to the frame. In an embodiment one or more of the roller assemblies are selectively drivable to controllably drive the movement of the body in the pitch direction, the yaw direction and the roll direction relative to the frame. The motion device provides for control rotation of the body in a desired direction such as the pitch, roll or yaw direction, a desired speed of rotation of the body and a desired acceleration of the body.
    Type: Application
    Filed: September 17, 2014
    Publication date: August 18, 2016
    Inventor: Ross Stewart Maclennan
  • Publication number: 20160222113
    Abstract: The present invention provides antibodies and antigen-binding fragments that specifically bind PD-1 (Programmed Death 1), thereby modulating immune responses in general, and those mediated by TcR and CD28, in particular. The disclosed compositions and methods may be used for example, in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer and other immune system disorders.
    Type: Application
    Filed: September 9, 2014
    Publication date: August 4, 2016
    Applicant: MedImmune Limited
    Inventors: Andrew Buchanan, Ross Stewart, Mathieu Chodorge
  • Publication number: 20160051672
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Application
    Filed: June 16, 2015
    Publication date: February 25, 2016
    Inventors: Ross STEWART, Michelle Morrow, Robert Wilkinson, Edmund Poon, Simon Dovedi, Tim Illidge
  • Patent number: 9267918
    Abstract: A flow cell for a microfluidic device can include a chamber, first microfluidic entry and exit channels, second microfluidic entry and exit channels, a first electrode, and a second electrode. A microfluidic device can include a microfluidic channel, a laser to excite fluorescent material, and a detector to detect fluorescence emission. Methods of merging a droplet from an emulsion in to a second stream of fluid and of detecting a content of a droplet in a stream are further disclosed.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: February 23, 2016
    Assignees: Cambridge Enterprise Limited, Sphere Fluidics Limited, SDIX, LLC
    Inventors: Tony R. Joaquim, Lewis Joe Stafford, Ross Stewart Chambers, Xin Liu, Clive Adrian Smith, Xin Li, Graeme Whyte
  • Publication number: 20160031990
    Abstract: Provided herein are methods of treating HPV-negative tumors comprising administering an effective amount of an antagonist of the PDL-1/PD-1 interaction (e.g., an anti-PDL-1 or anti-PD-1 antibody antigen binding fragment thereof).
    Type: Application
    Filed: May 28, 2015
    Publication date: February 4, 2016
    Inventors: Keith STEELE, Marlon C. Rebelatto, John Andrew Blake-Haskins, Paul B. Robbins, James R. Vasselli, Ross A. Stewart, Ramy Ibrahim, Aiman Shalabi
  • Patent number: 9211898
    Abstract: A golf trolley configured with a foldable chassis, a plurality of wheels for engagement with the ground, the wheels being movable between an operative position and a stowed position, and a handle. The trolley incorporates a gear train in connection with the foldable chassis for folding elements of the chassis with respect to one another and for moving the wheels between the operative and stowed positions. The handle is pivotally mounted to the chassis and includes a first gear, the first gear being in meshing engagement with the gear train for controlling the folding of the chassis by movement of the handle.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: December 15, 2015
    Assignee: Stewart Golf Limited
    Inventors: Mark Adam Stewart, Duncan Ross Stewart, Jon Stewart Miller, David Michael Funnell